Infections associated with ruxolitinib: study in the French Pharmacovigilance database
Sign Up to like & getrecommendations! Published in 2018 at "Annals of Hematology"
DOI: 10.1007/s00277-018-3242-8
Abstract: Dear Editor, Ruxolitinib, an orally bioavailable potent and selective inhibitor of Janus kinases (JAKs) 1 and 2, has been approved in Europe for the treatment of myelofibrosis and polycythemia vera. Ruxolitinib improves disease-related constitutional symptoms,… read more here.
Keywords: ruxolitinib; french pharmacovigilance; pharmacovigilance database; myelofibrosis ... See more keywords
Gabapentinoids and sleep apnea syndrome: a safety signal from the WHO pharmacovigilance database.
Sign Up to like & getrecommendations! Published in 2019 at "Sleep"
DOI: 10.1093/sleep/zsy242
Abstract: Introduction & Background: Due to the structural similarity between gabapentin and baclofen, gabapentin was reported to produce ‘baclofen-like’ effects. Baclofen is linked to sleep apnea syndrome (SAS), aggravating sleep-disordered breathing by depressing central ventilatory drive… read more here.
Keywords: pharmacovigilance database; gabapentinoids sleep; apnea syndrome; sleep apnea ... See more keywords
The drugs that mostly frequently induce acute kidney injury: a case − noncase study of a pharmacovigilance database
Sign Up to like & getrecommendations! Published in 2017 at "British Journal of Clinical Pharmacology"
DOI: 10.1111/bcp.13216
Abstract: AIMS Acute kidney injury (AKI) is associated with a high hospitalization rate, accelerated long-term decline in kidney function and a high mortality rate. Adverse drug reactions (ADRs) constitute one of the most important modifiable factors… read more here.
Keywords: drug; pharmacovigilance database; acute kidney; study ... See more keywords
ADVERSE DRUG REACTION-RELATED TO DRUG SHORTAGE: A RETROSPECTIVE STUDY ON THE FRENCH NATIONAL PHARMACOVIGILANCE DATABASE.
Sign Up to like & getrecommendations! Published in 2022 at "British journal of clinical pharmacology"
DOI: 10.1111/bcp.15550
Abstract: AIM Drug shortage is a growing global health issue. The aim of the study was to evaluate the consequences of drug shortages on patient safety based on data recorded in the French Pharmacovigilance Database. METHODS… read more here.
Keywords: pharmacovigilance database; drug; study; drug shortage ... See more keywords
Gingival bleeding, a possible “serious” adverse drug reaction: An observational study in the French PharmacoVigilance Database
Sign Up to like & getrecommendations! Published in 2017 at "Journal of Clinical Periodontology"
DOI: 10.1111/jcpe.12770
Abstract: INTRODUCTION Antithrombotic drugs are known to increase the risk of gingival bleeding because they affect coagulation. However, other drugs could also be involved in gingival bleeding. AIM We performed a pharmacoepidemiological study to identify the… read more here.
Keywords: french pharmacovigilance; pharmacovigilance database; gingival; gingival bleeding ... See more keywords
Drug‐induced sarcoidosis: an overview of the WHO pharmacovigilance database
Sign Up to like & getrecommendations! Published in 2019 at "Journal of Internal Medicine"
DOI: 10.1111/joim.12991
Abstract: There is a documented association between drug exposure and sarcoidosis‐like reactions. In this study, we used the largest pharmacovigilance database to describe drug‐induced sarcoidosis. read more here.
Keywords: drug; pharmacovigilance database; induced sarcoidosis; drug induced ... See more keywords
Pregnancy outcomes from the global pharmacovigilance database on interferon beta-1b exposure
Sign Up to like & getrecommendations! Published in 2020 at "Therapeutic Advances in Neurological Disorders"
DOI: 10.1177/1756286420910310
Abstract: Background: The goal of the present cohort study was to review outcomes of patients exposed to interferon beta-1b during pregnancy. Methods: Pregnancy cases with exposure to interferon beta-1b reported to Bayer’s pharmacovigilance (PV) database from… read more here.
Keywords: interferon beta; pharmacovigilance database; pregnancy; beta ... See more keywords
Potential kidney damage associated with the use of remdesivir for COVID-19: analysis of a pharmacovigilance database.
Sign Up to like & getrecommendations! Published in 2021 at "Cadernos de saude publica"
DOI: 10.1590/0102-311x00077721
Abstract: The U.S. Food and Drug Administration (FDA) has stated that the prescription of remdesivir should be cautious for patients with estimated glomerular filtration rate (eGFR) < 30 and some studies reported risk of adverse renal… read more here.
Keywords: renal urinary; remdesivir; pharmacovigilance database; use remdesivir ... See more keywords